Cost‐Effectiveness of 18F ‐Choline PET / CT Versus MIBI SPECT / CT for Preoperative Localization in Primary Hyperparathyroidism in the Colombian Healthcare System
Head & Neck · 2026
DOI: 10.1002/hed.70204 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Head & Neck, 2026. Verfasst von Figueroa-Bohórquez David und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Head and Neck Surgery, School of Medicine, Universidad de Antioquia, Medellin, Colombia. Hauptthemen laut MEDLINE: Choline, Hyperparathyroidism, Primary, Parathyroid Neoplasms, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Introduction
Primary hyperparathyroidism (PHPT) is a common endocrine disorder, most often caused by a single parathyroid adenoma, for which parathyroidectomy is the treatment of choice. Accurate preoperative localization is essential for focused surgery. In Colombia, technetium‐99 m sestamibi SPECT/CT (MIBI‐SPECT/CT) is the standard, though limited by low sensitivity. 18F‐choline PET/CT offers superior accuracy but at a higher cost. The only randomized trial comparing both modalities is the APACH2 study (Quak et al.).
Methods
We developed a cost‐effectiveness study using three decision‐analytic models, incorporating Colombian healthcare costs, diagnostic accuracy, and surgical outcomes based on APACH2 data. One was deterministic, while two used probabilistic approaches: one directly from trial results and another adapted to local clinical practice. Decision trees assumed that imaging strategies lead to different costs and outcomes.
Results
In all models, upfront PET/CT was more costly but also more effective than MIBI‐SPECT/CT, with an incremental cost‐effectiveness ratio below Colombia's willingness‐to‐pay (WTP) threshold. Sensitivity analyses identified normocalcemia probability, test sensitivity, and imaging cost as main drivers. In probabilistic and adapted models, PET/CT remained cost‐effective, exceeding 99% probability when WTP surpassed COP 4 000 000 per additional cured patient.
Conclusions
18F‐choline PET/CT is a clinically useful and cost‐effective strategy for preoperative localization in PHPT compared with MIBI‐SPECT/CT. These findings support its selective adoption in diagnostic algorithms and inform healthcare policy decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Head and Neck Surgery, School of Medicine, Universidad de Antioquia, Medellin, Colombia.
- CEXCA, Centro de Excelencia en Enfermedades de Cabeza y Cuello, Medellín, Colombia.
ORCID-Profile: Figueroa-Bohórquez David, Sanabria Alvaro
Zitieren
APA
David, F. B., Laura, M., & Alvaro, S. (2026). Cost‐Effectiveness of 18F ‐Choline PET / CT Versus MIBI SPECT / CT for Preoperative Localization in Primary Hyperparathyroidism in the Colombian Healthcare System. Head & Neck. https://doi.org/10.1002/hed.70204
Vancouver
David FB, Laura M, Alvaro S. Cost‐Effectiveness of 18F ‐Choline PET / CT Versus MIBI SPECT / CT for Preoperative Localization in Primary Hyperparathyroidism in the Colombian Healthcare System. Head & Neck. 2026. doi:10.1002/hed.70204
BibTeX
@article{David2026,
author = {David, Figueroa-Bohórquez and Laura, Mendieta and Alvaro, Sanabria},
title = {Cost‐Effectiveness of 18F ‐Choline PET / CT Versus MIBI SPECT / CT for Preoperative Localization in Primary Hyperparathyroidism in the Colombian Healthcare System},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70204}
}
EUVIMED